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ABSTRACT 
Objective: The current work envisages synthesis of novel ursolic acid derivatives and characterization by spectral methods that can be possible 
candidates for anti-inflammatory and anticancer activity. 
Methods: A series of imine and phthalic acid derivatives of ursolic acid (3β-hydroxyurs-12-en-28-oic acid), have been synthesized. 3-hydroxyimino-
urs-12-en-28-olic acid was treated with alkyl halide in the presence of sodium hydride in ethanol to yield 3-alkyloxyimino-urs-12-en-28-oic acid 
and further converted to its ester derivatives. Ursolic acid was reacted with phthalic anhydride in pyridine to get mono and di-substituted ester 
derivatives. 
Results: Novel substituted imino and pthalic derivatives were synthesized. The compounds synthesized were characterized by MS, IR, 1
Conclusion: The derivatives prepared may facilitate designing of similar newer analogues which may be useful for generating possible candidates 
from ursolic acid for anti-imflammatory and anti-cancer potential. Ursolic acid oximes and its anhydrides exhibit valuable biological properties and 
are important starting materials for further transformations. 
H and [13]C-
NMR spectroscopy.  
Keywords: Ursolic acid, Alkyl halide, Nucleophilic substitution, Anti-cancer. 
 
INTRODUCTION 
Natural triterpenoids isolated from various medicinal plants now 
seem to have a prominent role in the chemo-prevention and therapy 
of a variety of ailments and some have already entered clinical trials. 
One such important and highly investigated pentacyclic triterpenoid, 
ursolic acid has attracted great attention of late for its potential as a 
chemopreventive and chemotherapeutic agent in various types of 
cancer [1]. Ursolic acid sometimes referred as urson, malol, or 3-β-
hydroxy-urs-12-ene-28-oic-acid, is a pentacyclic triterpenoid 
present in Nerium indicum leaf, a common indigenous plant of India. 
Ursolic acid is present in 1.7- 2.0% concentration in leaf. A simple 
method to isolate this phytoconstituent has been devised by authors 
in previous communication [2]. Derivatives of ursolic acid can also 
be used in cosmetics because triterpenoids transport biologically 
active compounds deep into tissue and make them more potent [3].  
Ursolic acid is known to possess a host of biological activities 
besides also used in cosmetic industry. Ursolic acid exhibits diverse 
pharmacological activities, amongst which the anticancer and anti-
inflammatory activity has been most exhaustively studied. It inhibits 
NF-κB activation in both human intestinal epithelial cells and 
macrophages, and attenuates experimental murine colitis suggesting 
a potential therapeutic agent for inflammatory bowel disease [4]. 
Ursolic acid is reported to cause DNA fragmentation, activate 
caspases and down regulates expression of Bcl-2 in hepatocellular 
cancer cells [5]. It also induced differentiation of U937 cells by 
activating the PI3K/Akt pathway, and could be a potential candidate 
as a differentiation-inducing agent for the therapy of leukemia [6].  
Considering the immense anti-cancer potential of ursolic acid an 
extensive study has been done for synthesis of derivatives of this 
molecule. A regioselective approach using Huisgen 1,3-dipolar 
cycloaddition reaction of ursolic acid-alkyne derivative with various 
aromatic azides was employed to target an array of triazolyl 
derivatives against MCF-7, HCT-116, FR-2and THP-1 human 
epithelial cell line [7]. Chemical modification of this scaffold by an 
isopropyl ester moiety at C-17-COOH and a succinyl moiety at C-3-
OH showed potent inhibitory effect on growth of NTUB1 
cells suggesting that the presentation of G1 phase arrest and 
apoptosis mediated through increased amount of ROS in cells [8]. An 
α,β unsaturated ketone in conjugation with a heterocyclic ring at the 
ring 3-OH has improved antiproliferative activities against AsPC-1 
pancreatic cancer cells by arresting cell cycle in G1 phase and 
inducing apoptosis with upregulation of p53, p21waf1 and NOXA 
protein levels [9]. Structural activity relationship (SAR) reveals the 
C-3, C-28 and C-11 positions of ursolic acid important with respect 
to the cytotoxic potential. Introduction of an amino group increases 
the cytotoxicity greatly while 3β-amino increased the potency by 
several manifold than the parent ursolic acid [10]. The derivatives 
with a substituted acetyl group at C3 hydroxyl group show better 
activities than those with an unsubstituted hydroxyl group against 
Hela cell line [11]. 
3-hydroxyiminours-12-en-28-oic acid (A) and 3-[[2-(hydroxyl 
carbonyl)  benzoyl] oxy] urs-12-en-28-oic acid (D) has been 
reported as key intermediates for the synthesis of different variety 
of ursolic acid derivatives. In view of the reported SAR 
considerations the currenty work envisages partial synthesis of 
imine and phthalic anhydride derivatives of ursolic acid. The 
derivatives prepared may act as new potential agents for the anti-
cancer and anti-inflammatory activity.  
MATERIALS AND METHODS 
All reagents used were of analytical grade and purchased from S. D. 
Fine Chemicals, Mumbai. Isolation of ursolic acid was done by 
extracting leaves of N. Indicum with methanol and the extract was 
basified to separate the triterpinoid, followed by charcoal treatment 
and subsequent acidification method published previously by the 
authors. The course of reaction and purity of product was monitored 
by TLC on Merck 60 F254 silica plates using the mobile phase of ethyl 
acetate: ether (2:8) and observation under UV light (254 nm). IR 
spectrum was recorded on Perkin Elmer Spectrum10 Mass spectrum 
of compounds was recorded on Micromass Q-TOF MS mass 
spectrometer. All 1H NMR and [13]C spectras was recorded on JOEL 
300 MHz and 75 MHz instrument respectively, with an internal 
standard of tetramethylsilane (TMS). 
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The reaction scheme for substituted derivatives of 3-hydroxyimino-
urs-12-en-28-oic acid (Table 1) has been summarized in Scheme-I. 
The reaction scheme for the substituted derivatives of 3-[[2-
(hydroxycarbonyl) benzoyl] oxy] urs-12-en-28-oic acid (Table 2) 
has been summarized in Scheme-II.  
General method for synthesis of 3-alkyloxyimino-urs-12-en-28-
oic acid (B) 1-5 compounds (Table 1) 
3-hydroxyiminours-12-en-28-oic acid (A) (200 mg, 0.43 mmol) was 
added in (5 ml) tetrahydrofuran (THF) at 0 - 5o
To a stirred solution of 3-alkyloxyiminours-12-en-28-oic acid (B) 
(100 mg, 0.20 mmol), potassium carbonate (33.17 mg, 0.24 mmol), 5 
ml ethanol was added and refluxed at 65-67°C for 8 hr. Thereafter 
alkyl substrate was added dropwise, and the reaction was stirred till 
complete. The progress of the reaction was monitored by TLC. After 
completion, the reaction mixture was concentrated to remove 
ethanol and was quenched with water. The product was extracted 
with ethyl actate (1 × 10 ml) and washed with brine water, dried 
over sodium sulphate and concentrated. The product was purified 
by silica gel column chromatography using pet-ether: ethyl acetate 
(70:30) to give colorless solid product (C). 
C. The solution was 
cooled and to it sodium hydride (NaH) (15.48 mg, 0.64 M) was 
added and stirred for 0.5 hr. Then alkyl substrate was then added to 
the reaction. The reaction was monitored by TLC to check its 
completion. The reaction was quenched with water and extracted 
with ethyl acetate (2 × 20 ml). The product was purified by column 
chromatography using pet-ether: ethyl acetate (8:2) as eluent and 
gave white color solid (B) with the good yield. 
General method for synthesis 3-alkyloxyiminours-12-en-28-oic 































Scheme I: Synthesis of 3-alkyloxyimino-urs-12-en-28-oic acid 
(B) and 3-alkyloxyiminours-12-en-28-oic acid alkyl ester (C) 
[(a) THF, NaH, alkyl substrate 0-5°C; (b) ethanol, K2CO3, alkyl 
substrate 65-67°C].
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Table 2: Pthalic acid derivatives of 3-[[2-(alkyloxycarbonyl)benzoyl]oxy]urs-12-en-28-oic acid (E) and 3-[[2-
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14.26/ 0.70 3-[[2-(methoxycarbonyl) benzoyl]oxy]urs-12-en-
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27.91/ 0.23 3-((2-((allyloxy)carbonyl) benzoyl)oxy)urs-12-en-
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49.22/ 0.28 3-[[2[(benzyloxy)carbonyl] benzoyl]oxy]urs-12-


























77.44/ 0.38 3-[(2-oxo-2-phenylethoxy) carbonyl]urs-12-en-28-






































Scheme II: Synthesis of 3-[[2-(alkyloxycarbonyl)benzoyl] 
oxy]urs-12-en-28-oic acid (E) and 3-[[2-(alkyloxycarbonyl) 
benzoyl]oxy]urs-12-en-28-oic acid alkyl ester (F) [(c) ethanol, 
K2CO3, alkyl substrate 55-600C; (d) ethanol, K2CO3, alkyl 
substrate 65 -670
General method for synthesis of 3-[[2-(alkyloxycarbonyl) 
benzoyl] oxy]-urs-12-en-28-oic acid (E) compounds 11-15 
(Table 2) 
C]. 
To a solution of 3-[[2-(hydroxycarbonyl) benzoyl] oxy] urs-12-en-
28-oic acid (D) (200 mg, 0.33 mmol) and potassium carbonate 
(31.99 mg, 0.23 mmol) was added into 10 ml ethanol and refluxed 
for 8 hrs. Alkyl substrate was added and mixture was stirred at 55-
60°C till completion of reaction. After completion, the reaction was 
quenched with ice at room temperature and extracted with ethyl 
acetate (2× 20 ml). The combined organic layer was washed with 
brine, dried over sodium sulphate and the solvent evaporated to 
dryness. The crude product was purified by column chromatography 
using pet-ether: ethyl acetate (80:20) as mobile phase to give off 
white product (E). 
General method for synthesis 3-[[2-(alkyloxycarbonyl) 
benzoyl]oxy]urs-12-en-28-oic acid alkyl ester (F) compunds 16-
20 (Table 2) 
3-[[2-(alkyloxycarbonyl)benzoyl]oxy]urs-12-en-28-oic acid (E) and 
potassium carbonate (15.99 mg, 0.11 mmol) was added into 5 mL 
ethanol and refluxed for 8-10 hrs to make potassium salt and water 
was removed by Dean Stark apparatus. Alkyl substrate was added 
Babar et al. 




and mixture was stirred at 65-67°C till reaction was complete. After 
completion (monitored by TLC), the reaction was quenched with ice 
at room temperature, extracted with ethyl acetate (2× 20 ml), the 
combined organic layers washed with brine, dried over sodium 
sulphate and the solvent evaporated to dryness. The crude product 
was purified by column chromatography using pet-ether: ethyl 
acetate (80:20) to give off white product (F).  
3-methoxyiminours-12-en-28-oic acid (1) 
Yield: 63%, m. p. 120-122°C. IR (KBr): 3423, 1680 cm-1; 1H NMR 
(300 MHz, CHCl3): δ 3.8 (s, 3H, OCH3, H-R1), 5.2 (s, 1H, alkene 
proton); [13]C NMR (75 MHz CHCl3): δ 58 (-OCH3), 125 and 135 
(alkene group carbons), 165 (acid group carbon). MS: m/z 483.50 
[M]+, calcd for C31H49NO3
3-allyloxyiminours-12-en-28-oic acid (2) 
 (483.73). 
Yield: 64%, m. p. 111-113°C. IR (KBr, cm-1): 3420 (-O-H of acidic 
group), 1685 (-C=O of acidic group); 1H NMR (300 MHz, CHCl3): δ 
3.8 (d, 2H, -OCH2 allylic protons, H-R1), 5.1, 5.7, 5.8 (m, 3H, alkene 
protons, H-R1); [13]C NMR (75 MHz, CHCl3): δ 65 (-OCH2 allylic 
carbon), 118-130 (alkene group carbon), 170 (acid group carbon); 
MS: m/z 510.60 [M]+, calcd for C33H51NO3
3-benzyloxyiminours-12-en-28-oic acid (3) 
 (509.76). 
Yield: 50%. m. p. 125-127°C. IR (KBr cm-1): 3448 (-O-H of acid 
group), 1700 (-C=O of acid group), 1458-1603 (C=C of aromatic 
ring). 1H NMR (300 MHz, CHCl3): δ 3.0 (s, 2H, -CH2 benzylic proton), 
δ 7.6-7.8 (m, 5H, corresponds to aromatic protons); [13]C NMR (75 
MHz, CHCl3): δ 60 (-OCH2 benzyl carbon), 125-150 (aromatic 
carbons), 185 (acid group carbon); MS: m/z 559.40 [M]+, calcd for 
C37H53NO3
3-[(2-ethoxy-2-oxoethoxy) imino]-urs-12-en-28-oic acid (4) 
 (559.82). 
Yield: 57%. m. p. 140-142°C. IR (KBr, cm-1): 3441 (-O-H of acid group), 
1670-1730 (-C=O of acid and ester group), 1100-1300 (-O-CH2 of 
ester group); 1H NMR (300MHz, CHCl3): δ 4.2 (t, 3H, CH3-CH2, H-R1), 
4.5 (s, 2H, -OCH2-C=O, H-R1), 4.8 (q, 2H, -OCH2-CH3); [13]C NMR (75 
MHz, CHCl3): δ 20 (CH3), 60 (O-CH2), 170-178 (acid and ester group 
carbons); MS: m/z 555.60 [M]+, calcd for C34H53NO5 (555.79). 
3-[(2-oxo-2-phenylethoxy) imino]-urs-12-en-28-oic acid (5) 
Yield: 60%. m. p. 133-135°C. IR (KBr, cm-1): 3448 (O-H of acid 
group), 1680-1725 (C=O of acid and ketone group), 1450-1600 (C=C 
of aromatic ring); 1H NMR (300MHz, CHCl3): δ 4.7 (s, 2H, -O-CH2-
C=O), 7.2-7.8 (m, 5H, aromatic protons); [13]C NMR (CHCl3, 75 
MHz): δ 60 (-OCH2), 125-140 (aromatic carbans), 165, 185 (acid and 
ester group carbon); MS: m/z 587.60 [M]+, calcd for C38H53NO4
3-Methoxyiminours-12-en-28-oic acid methyl ester (6) 
 
(587.83). 
Yield: 61%. m. p. 105-106°C. IR (KBr, cm-1): 1720 (-C=O of ester 
group), 1448 (-C=C of alkene); 1H NMR (300 MHz, CHCl3): δ 3.8 (s, 
3H, -OCH3, H-R1), 3.9 (s, 3H, -OCH3 ester group protons, H-R2), 5.1 
(s, 1H, -CH= alkene proton); [13]C NMR (75 MHz, CHCl3): δ 58-65 
(two methoxy group carbons), 125-140 (alkene carbans), 168 (-C=O 
corresponds to ester carbon); MS: m/z 497.20 [M]+, calcd. for 
C32H51NO3
3-allyloxyiminours-12-en-28-oic acid allyl ester (7) 
 (497.75). 
Yield: 64%. m. p. 112-114°C. IR (KBr, cm-1): 1730 (-C=O of ester 
group), 1400-1500 (-C=C of allyl group); 1H NMR (300MHz, CHCl3): 
δ 2.8 (m, 2H, -OCH2 allylic protons, H-R1), 4.7 (m, 2H, -OCH2 allylic 
methyl group protons attached to ester group, H-R2), 5.1, 5.7, 5.9, 
6.1, 6.3, 6.7 (m, 6H, 2(-CH=CH2)). [13]C NMR (75 MHz, CHCl3): δ 64 
(CH2), 65 (CH2), 118, 125, 130, 135 (2(-CH=CH2)), 165 (C=O); MS: 
m/z 549.60 [M]+, calcd. for C36H55NO3
3-benzyloxyiminours-12-en-28-oic acid benzyl ester (8) 
 (549.83). 
Yield: 60%. M. p. 110-115°C. IR (KBr, cm-1): 1735 (C=O), 1500-1600 
(aromatic -C=C); 1H NMR (300 MHz, CHCl3): δ 3.7 (s, 2H, CH2, H-R1), 
3.9 (s, 2H, CH2,  H-R2), 7.8 (s 5H, Ar-H, H-R1), 7.9 (s 5H, Ar-H, H-R2); 
[13]C NMR (75 MHz, CHCl3): δ 58 (CH2), 59 (CH2), 120, 122, 130, 
135, 140, 142, 150, 155 (aromatic carban), 160 (C=O); MS: m/z 
648.70 [M]+, calcd. for C44H59NO3
3-[(2-ethoxy-2-oxoethoxy) imino]-urs-12-en-28-oic acid [2-
ethoxy-2-oxoethyl] ester (9) 
 (649.93). 
Yield: 57%. m. p. 105-107 °C. IR (KBr, cm-1): 1728 (C=O), 1400-1500 
(-C=C); 1H NMR (300 MHz, CHCl3): δ 2.5 (s, 2H, CH2, H-R1), 2.8 (s, 
2H, CH2, H-R2), 3.3 (q, 2H, CH2, H-R1), 3.8 (q, 2H, CH2, H-R2), 3.7 (t, 
3H, CH3, H-R1), 4.4 (t, 3H, CH3, H-R2), 5.1 (s, 1H,CH=C); [13]C NMR 
(CHCl3 , 300 MHz): δ 20, 25 (CH3), 58, 59, 63, 65 (OCH2), 170 (C=O); 
MS: m/z 641.3 [M]+, calcd. for C38H59NO7
3-[(2-oxo-2-phenylethoxy) imino]-urs-12-en-28-oic acid [2-oxo-
2-phenylethyl] ester (10) 
 (641.88). 
Yield: 61%. m. p.: 116-118°C. IR (KBr): 1730 (C=O), 1500-1600 (Ar-
C=C); 1H NMR (300 MHz, CHCl3): δ 3.5 (s, 2H, CH2, H-R1), 3.7 (s 2H, 
CH2, H-R2), 5.1 (s, 1H, CH=C), 7.4 (m, 5H, Ar-H, H-R1), 7.8 (m, 5H, Ar-
H, H-R2); [13]C NMR (75 MHz, CHCl3): δ 57, 58 (CH2), 115, 120, 118, 
125, 138 (Ar-C), 170, 185 (C=O); MS: m/z 705.30 (M+), calcd. for 
C46H59NO5
3-[[2-(methoxycarbonyl)benzoyl]oxy]urs-12-en-28-oic acid (11) 
 (705.96). 
Yield: 73%. m. p. 150-152°C. IR (KBr, cm-1): 1735 (C=O), 1500-1600 
(Ar-C=C), 1448 (C=C); 1H NMR (300 MHz, CHCl3): δ 3.1 (s, 3H, CH3, 
H-R3), 3.8 (s, 1H, CH), 7.3-7.8 (m, 4H, Ar-H); [13]C NMR (75 MHz, 
CHCl3): δ 55, 59 (O-CH3), 125, 140 (Ar-C), 165 (C=O); MS: m/z 
618.00 [M]+, calcd. for C39H54O6
3-[[2-[(allyloxy) carbonyl]benzoyl]oxy]urs-12-en-28-oic acid (12) 
 (618.84). 
Yield: 61%. m. p. 152-154°C. IR (KBr, cm-1): 1740 (C=O), 1500-1600 
(Ar-C=C), 1400-1500 (C=C); 1H NMR (300 MHz, CHCl3): δ 5.5, 5.7, 
5.9 (m, 3H, OCH=CH2, H-R3), 7.3-7.9 (m, 4H, Ar-H); [13]C NMR (75 
MHz, CHCl3): δ 62 (OCH2), 118, 130, 135, 139 (-CH=CH2), 170 
(C=O); MS: m/z 644.40 [M]+, calcd. for C41H56O6
3-[[2-[(benzyloxy) carbonyl] benzoyl] oxy] urs-12-en-28-oic acid 
(13) 
 (644.88). 
Yield: 61%. m. p. 161-163°C. IR (KBr, cm-1): 1730 (C=O), 1500-1600 
(Ar-C=C); 1H NMR (300MHz, CHCl3): δ 4.0 (s, 2H, CH2, H-R3), 7.2-7.5 
(m, 4H, Ar-H), 7.9 (s, 5H, Ar-H, H-R3); [13]C NMR (75 MHz, CHCl3): δ 
55 (O-CH3), 59 (O-CH3), 120, 125, 130, 140, 150 (Ar-C), 185(C=O); 
MS: m/z 693.90 [M]+, calcd. for C45H58O6
3-[[2-[(2-ethoxy-2-oxoethoxy) carbonyl] benzoyl] oxy] urs-12-
en-28-oic acid (14) 
 (694.94). 
Yield: 65%. m. p. 155-157°C. IR (KBr, cm-1): 1725 (C=O), 1500-1600 
(Ar-C=C) cm-1, 1400-1500 (C=C); 1H NMR (300MHz, CHCl3): δ 4.2 (t, 
3H, CH3, H-R3), 4.4 (q, 2H, CH2, H-R3), 7.5, 79 (m, 4H, Ar-H); [13]C 
NMR (75 MHz, CHCl3): δ 30 (-CH3), 55 (O-CH2), 62 (O-CH2), 140 (Ar-
C), 177 (C=O); MS: m/z 690.70 [M]+, calcd. for C42H58O8 
3-[[2-[(2-oxo-2-phenylethoxy) carbonyl] benzoyl] oxy] urs-12-
en-28-oic acid (15) 
(690.91). 
Yield: 54%. m. p. 142-144°C. IR (KBr, cm-1): 1732 (C=O), 1500-1600 
(Ar-C=C), 1400-1500 (C=C). 1H NMR (300 MHz, CHCl3): δ 4.1 (s, 2H, 
CH2, H-R3), 7.2-7.9 (m, 4H, Ar-H), 8.0 (m, 5H, Ar-H, H-R3); [13]C 
NMR (75 MHz, CHCl3): δ 55 (O-CH2), 121, 138, 145 (Ar-C), 165, 185 
(C=O); MS: m/z 722.30 [M]+, calcd. for C46H58O7
3-[[2-(methoxycarbonyl)benzoyl]oxy]urs-12-en-28-oic acid 
methyl ester (16) 
 (722.30). 
Yield: 72%. m. p. 130-132°C. IR (KBr, cm-1): 1725 (C=O), 1500-1600 (Ar-
C=C) cm-1, 1400-1500 (C=C); 1H NMR (300MHz, CHCl3): δ 4.2 (s, 3H, 
CH3, H-R3), 4.4 (s 3H, CH3, H-R4), 7.3-7.5 (m, 4H, Ar-H); [13]C NMR (75 
MHz, CHCl3): δ 55 (OCH3), 59 (OCH3), 122, 125, 130, 135 (Ar-C), 165, 
170, 180 (C=O); MS: m/z 632.70 [M]+, calcd. for C40H56O6 (632.87). 
3-[[2-[(allyloxy) carbonyl] benzoyl] oxy] urs-12-en-28-oic acid 
allyl ester (17) 
Yield: 64%. m. p. 132-134°C. IR (KBr, cm-1): 1730 (C=O), 1500-1600 
(Ar-C=C), 1400-1500 (C=C); 1H NMR (300 MHz, CHCl3): δ 5.1 (s, 1H, 
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CH=C, H-R3), 5.3 (s, 1H, CH=C, H-R4), 5.5-6.1 (m, 3H, CH=CH2, H-R3), 
7.2-7.9 (m, 4H, Ar-H, H-R4); [13]C NMR (75 MHz, CHCl3): δ 65 (O-
CH2), 70 (O-CH2), 110, 125, 130, 140 (Ar-C), 161, 170 (C=O); MS: 
m/z 684.30 [M]+, calcd. for C44H60O6 (684.94). 
3-[[2-[(benzyloxy) carbonyl] benzoyl] oxy]urs-12-en-28-oic 
acid benzyl ester [18] 
Yield: 54%. m. p. 121-123°C. IR (KBr, cm-1): 1735 (C=O), 1500-1600 
(Ar-C),1400 (C=C); 1H NMR (300 MHz, CHCl3): δ 3.8 (s, 1H, OCH2, H-
R3), 4.1 (s, 1H, OCH2, H-R4), 7.1-7.3 (m, 4H, Ar-H), 7.5 (s 5H Ar-H, H-
R3), 8.1 (s, 5H, Ar-H, H-R4); [13]C NMR (75 MHz, CHCl3): δ 62 (O-
CH2), 65 (O-CH2), 125, 130, 135, 140, 145 (Ar-C), 168, 180, 185 
(C=O); MS: m/z 784.40 [M]+, calcd. for C52H64O6 (785.06). 
3-[[2-[(2-ethoxy-2-oxoethoxy) carbonyl]benzoyl]oxy]urs-12-
en-28-oic acid [2-ethoxy-2-oxoethyl] ester (19) 
Yield: 62%. M. p.121-123°C. IR (KBr, cm-1): 1740 (C=O), 1500-1600 
(Ar-C), 1450 (C=C); 1H NMR (300 MHz, CHCl3): δ 3.6 (t, 3H, CH3, H-
R3), 3.8(s, 2H, OCH2, H-R3), 4.1 (q, 2H, OCH2, H-R3), 4.2 (t, 3H, CH3, 
H-R4), 4.3 (s, 2H, OCH2, H-R4), 4.4 (q, 2H, OCH2, H-R4); [13]C NMR 
(75 MHz, CHCl3): δ 15, 22 (CH3), 55, 59, 60, 68 (OCH2) 122, 125, 
125, 130, 135 (Ar-C), 175, 180, 185 (C=O); MS: m/z 776.60 [M]+, 
calcd. for C46H64O10 (776.99). 
3-[(2-oxo-2-phenylethoxy) carbonyl] urs-12-en-28-oic acid-[2-
oxo-2-phenylethyl] ester (20) 
Yield: 59%. m. p. 135-137°C. IR (KBr, cm-1): 1730 (C=O), 1500-1600 
(aromatic carban), 1400-1500 (C=C); 1H NMR (300MHz, CHCl3): δ 
4.5 (s, 2H, OCH2, H-R3), 4.8 (s, 2H, OCH2, H-R4), 7.1- 7.8 (m, 4H, Ar-
H), 8.0 (s, 5H, Ar-H, H-R3), 8.2 (s, 5H, Ar-H, H-R4); [13]C NMR (75 
MHz, CHCl3): δ 45, 50 (OCH2), 110, 120, 125, 135 (Ar-C), 165, 
180,185 (C=O); MS: m/z 840.60 [M]+, calcd. for C54H64O8 (841.08). 
RESULTS AND DISCUSSION 
The aim of the present work was to study the reactivity of A and D 
towards the wide variety of substituted imine and substituted 
phthalic acid derivatives of ursolic acid and ursolic acid esters. 
Synthesis of compound A was done by the reaction of 3-ketoursolic 
acid, hydroxyl amine hydrochloride in ethanol as previously 
reported [12]. Synthesis of compound D was done by the reaction of 3-
ketoursolic acid and phthalic anhydride in pyridine as reported earlier 
[13]. Compounds A and D was identified by MS, 1
A one pot reaction of 3-hydroxyiminours-12-en-28-oic acid (A) and 
alkyl substrate in the presence of NaH in THF offered substituted 
imino compounds 3-methoxyiminours-12-en-28-oic acid 1, 3-
allyloxyiminours-12-en-28-oic acid 2, 3-benzyloxyiminours-12-en-
28-oic acid 3, 3-[(2-ethoxy-2-oxoethoxy)imino]-urs-12-en-28-oic 
acid 4, 3-[(2-oxo-2-phenylethoxy)imino]-urs-12-en-28-oic acid 5 in 
good yields (Scheme I), (Fig. 1). To prepare 3-alkyloxyiminours-12-
en-28-oic acid methyl ester (C), the compound 1, 2, 3, 4 and 5 was 
reacted with alkyl substrate in the presence of K
H and [13]C NMR. 
2CO3 in ethanol. 
Esterification occured to form 3-Methoxyiminours-12-en-28-oic acid 
methyl ester 6, 3-allyloxyiminours-12-en-28-oic acid allyl ester 7, 3-
benzyloxyiminours-12-en-28-oic acid benzyl ester 8, 3[(2-ethoxy-2-
oxoethoxy)imino]-urs-12-en-28-oic acid [2-ethoxy-2-oxoethyl] ester 
9, 3-[(2-oxo-2-phenylethoxy)imino]-urs-12-en-28-oic acid [2-oxo-2-
phenylethyl] ester 10 (Scheme I), (Fig. 1). For synthesizing 3-[[2-
(alkyloxycarbonyl)benzoyl]oxy]urs-12-en-28-oic acid (E), a one pot 
reaction of 3-[[2-(hydroxycarbonyl)benzoyl]oxy]urs-12-en-28-oic 
acid (D) and an alkyl substrate in the presence of K 2CO3 
The synthesized compounds were 3-[[2-(methoxycarbonyl) 
benzoyl] oxy]urs-12-en-28-oic acid methyl ester 16, 3-[[2-[(allyloxy) 
carbonyl]benzoyl]oxy]urs-12-en-28-oic acid allyl ester 17, 3-[[2-
[(benzyloxy) carbonyl] benzoyl] oxy]urs-12-en-28-oic acid benzyl 
ester 18, 3-[[2-[(2-ethoxy-2-oxoethoxy)carbonyl] benzoyl]oxy]urs-
12-en-28-oic acid [2-ethoxy-2-oxoethyl] ester 19, 3-[(2-oxo-2-
phenylethoxy) carbonyl] urs-12-en-28-oic acid-[2-oxo-2-
phenylethyl] ester 20. 
CONCLUSION  
In conclusion, twenty derivatives comprising of phthalic acid and 
imines have been prepared by using a cost effective approach and 
considering the extensive SAR studies done in the prior art. 
Prepared derivatives can be screened as leads for anticancer 
potential that may open the possibility for newer therapeutic 
actions. 
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